IBJNews

City set to cancel tax abatement for medical device firm

Back to TopCommentsE-mailPrintBookmark and Share

The city of Indianapolis is expected Wednesday to rescind a tax abatement given in 2007 to Polymer Technology Systems Inc., a small locally based maker of handheld blood monitors.

PTS, founded in 1992 by a former Roche Diagnostics Corp. employee, said it would make a $3 million investment at its operation on Zionsville Road and create 110 jobs by 2010 but fell short of its goal.

The company has made $2.1 million in investments and currently has only about 70 employees, less than the 80 it had when it received the abatement four years ago, according to the city.

Though the tax abatement spanned a 10-year period, terms of the agreement called for PTS to meet expectations by 2010. It’s not unusual for a project’s commitment date to occur before the end of the abatement in order to limit the city’s risk if a project doesn’t perform as expected, said Ryan Hunt, senior project manager for the Department of Metropolitan Development.
   
PTS has saved $17,207 in property taxes since the city approved the abatement in 2007 but had been expecting to save about $185,000 over the entire abatement period.
 
PTS may have been capable of meeting the commitments before the end of the abatement, Hunt said, but the company chose to agree to the termination rather than renegotiate the deal with the city.

The Metropolitan Development Commission is set to cancel the abatement at its meeting Wednesday afternoon.

PTS makes CardioChek, a handheld meter that quickly and accurately measures levels of cholesterol, glucose, triglycerides and other key health indicators from a drop of blood.

The company tapped global markets in the mid-2000s to spur fast growth but struggled to sustain the rapid pace during the recession and amid legal issues over a licensing agreement with Roche.
 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT